Redox Control in Acute Lymphoblastic Leukemia: From Physiology to Pathology and Therapeutic Opportunities
Acute lymphoblastic leukemia (ALL) is a hematological malignancy originating from B- or T-lymphoid progenitor cells. Recent studies have shown that redox dysregulation caused by overproduction of reactive oxygen species (ROS) has an important role in the development and progression of leukemia. The...
Main Authors: | Yongfeng Chen, Jing Li, Zhiqiang Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/5/1218 |
Similar Items
-
Extramedullary relapse of acute lymphoblastic leukemia in breast: A rare presentation
by: Thanka J, et al.
Published: (2010-01-01) -
Infant Acute Lymphoblastic Leukemia—New Therapeutic Opportunities
by: Marika Kulczycka, et al.
Published: (2024-03-01) -
Targeting Redox Regulation as a Therapeutic Opportunity against Acute Leukemia: Pro-Oxidant Strategy or Antioxidant Approach?
by: Alessandro Allegra, et al.
Published: (2022-08-01) -
Evaluation of Nitric Oxide production by monocytes in children with acute lymphoblastic leukemia
by: R Chegeni, et al.
Published: (2001-01-01) -
Treatment outcomes for acute T-lymphoblastic leukemias/lymphomas: data from the ALL-2016 multicenter prospective randomized trial
by: O. A. Aleshina, et al.
Published: (2023-03-01)